[1] 胡宇华,李江. 涎腺多形性腺瘤恶变机制的研究进展[J]. 国际口腔医学杂志, 2007, 34(6):449-451.
[2] Li J, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer[J]. Science, 1997, 275(5308):1943-1947.
[3] Chu EC, Tamawski AS.PTEN regulatory functions in tumor suppression and cell biology[J]. Med Sci Monit, 2004, 10(10):235-241.
[4] 涂明, 郑伟明. IL-13Rα2、VEGF和PTEN在人脑胶质瘤中的研究进展[J]. 医学综述, 2008, 14(13):1966-1969.
[5] 陈美霓, 郭巍, 贺智英, 等. 抑癌基因PTEN在膀胱癌中的研究进展[J]. 延安大学学报: 医学科学版, 2008, 6(1): 3-4.
[6] Parsons R. Human cancer, PTEN and the PI-3 kinase pathway[J]. Semin Cell Dev Biol, 2004, 15(2):171-176.
[7] 米登海,易继林. 瘤抑制基因PTEN在肝细胞癌中的研究进展[J]. 国外医学: 外科学分册, 2005, 32(5):334-338.
[8] Li DM, Sun H. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta[J]. Cancer Res, 1997, 57(11):2124-2129.
[9] Leslie NR, Gray A, Pass I, et al. Analysis of the cellular functions of PTEN using catalytic domain and C-terminal mutations: differential effects of C-terminal deletion on signalling pathways downstream of phosphoinositide 3-kinase[J]. Biochem J, 2000, 346(3):827-833.
[10] Shin KH, Kim JM, Rho KS, et al. Inactivation of the PTEN gene by mutation,exonic deletion,and loss of transcript in human oral squamous cell carcinomas[J]. Int J Oncol, 2002, 21(5):997-1001.
[11] Lee JI, Soria JC, Hassan KA, et al. Loss of PTEN expression as a prognostic marker for tongue cancer[J]. Arch Otolaryngol, 2001, 127(12):1441-1445.
[12] Zhang RH, Li CY. Mutation and deletion of tumor suppressor PTEN in pleomorphic adenoma of parotid gland and mucoepidermoid carcinoma of parotid gland[J]. J Oral Science Res, 2005, 21(1): 41-44.
[13] Sulis ML, Parsons R. PTEN: from pathology to biology[J].Trends Cell Biol, 2003, 13(9):478-483. |